Titre : | Marijuana and the lung: Evolving understandings (2022) |
Auteurs : | M. JOSHI ; A. JOSHI ; T. BARTTER |
Type de document : | Article : Périodique |
Dans : | Medical Clinics of North America (Vol.106, n°6, November 2022) |
Article en page(s) : | 1093-1107 |
Langues: | Anglais |
Discipline : | PAT (Pathologie organique / Organic pathology) |
Mots-clés : |
Thésaurus mots-clés CANNABIS ; POUMON ; APPAREIL RESPIRATOIRE ; FACTEUR DE RISQUE ; MECANISME D'ACTION ; TYPE D'USAGE ; CANCER ; SYMPTOME |
Résumé : |
Human beings have used marijuana products for centuries. Relatively recent data showing extensive cannabinoid receptors, particularly in the brain, help to explain the impacts of cannabinoids on symptoms/diseases, such as pain and seizures, with major nervous system components. Marijuana can cause bronchitis, but a moderate body of literature suggests that distal airway/parenchymal lung disease does not occur; marijuana does not cause chronic obstructive pulmonary disease and probably does not cause lung cancer, distinctly different from tobacco. Potentials for cognitive impairment and for damage to the developing brain are contextually important as its beneficial uses are explored.
Key points: - Marijuana can cause bronchitis and may have some impacts on pulmonary physiology, but, even when smoked, does not cause COPD. - Data with respect to lung cancer and marijuana are suboptimal, but a summary of current collective data argues against causality. - Marijuana use for recreational purposes should be discouraged in teens. |
Domaine : | Drogues illicites / Illicit drugs |
Sous-type de document : | Revue de la littérature / Literature review |
Refs biblio. : | 57 |
Affiliation : |
Pulmonary and Critical Care Division, University of Arkansas for Medical Sciences, Little Rock, AR, USA Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA |
Lien : | https://doi.org/10.1016/j.mcna.2022.07.010 |
Accueil